BRF Stock Forecast, Price & News

BRF (NYSE:BRFS) Frequently Asked Questions

Is BRF a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BRF in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BRF stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BRFS, but not buy additional shares or sell existing shares.
View analyst ratings for BRF or view top-rated stocks.

How has BRF's stock been impacted by COVID-19?

BRF's stock was trading at $3.95 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BRFS shares have decreased by 12.2% and is now trading at $3.47.
View which stocks have been most impacted by COVID-19.

Are investors shorting BRF?

BRF saw a increase in short interest in October. As of October 29th, there was short interest totaling 17,040,000 shares, an increase of 35.0% from the October 14th total of 12,620,000 shares. Based on an average trading volume of 3,430,000 shares, the short-interest ratio is presently 5.0 days.
View BRF's Short Interest.

When is BRF's next earnings date?

BRF is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for BRF.

How were BRF's earnings last quarter?

Brf S.A. (NYSE:BRFS) issued its quarterly earnings data on Monday, November, 9th. The company reported $0.05 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.08 by $0.03. The firm earned $1.85 billion during the quarter, compared to the consensus estimate of $1.83 billion. BRF had a trailing twelve-month return on equity of 5.28% and a net margin of 0.86%.
View BRF's earnings history.

What price target have analysts set for BRFS?

5 brokerages have issued 12-month price targets for BRF's stock. Their forecasts range from $3.50 to $6.40. On average, they anticipate BRF's share price to reach $5.33 in the next year. This suggests a possible upside of 53.7% from the stock's current price.
View analysts' price targets for BRF or view top-rated stocks among Wall Street analysts.

Who are BRF's key executives?

BRF's management team includes the following people:

• Lorival Nogueira Luz, Global Chief Executive Officer
• Vinícius Guimarães Barbosa, Vice President-Operations & Supplies
• Carlos Alberto Bezerra de Moura, Chief Financial Officer
• Leonardo Campo Dall'Orto, VP-Integrated Planning & Logistics
• Sidney Rogério Manzaro, Vice President-Commercial Brazil Region

What is José Fay's approval rating as BRF's CEO?

34 employees have rated BRF CEO José Fay on Glassdoor.com. José Fay has an approval rating of 40% among BRF's employees. This puts José Fay in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of BRF's key competitors?

Some companies that are related to BRF include Tingyi (Cayman Islands) (TCYMF), Darling Ingredients (DAR), Spirits Cap (CBEVD), Molson Coors Beverage (TAP), Want Want China (WWNTY), Newell Brands (NWL), Aramark (ARMK), New York Times (NYT), Lamb Weston (LW), Coty (COTY), Coca-Cola Amatil (CCLAY), US Foods (USFD), Pilgrim's Pride (PPC), Square Enix (SQNXF) and Ingredion (INGR).
View all of BRFS's competitors.

What other stocks do shareholders of BRF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BRF investors own include Hawkins (HWKN), Coty (COTY), Cracker Barrel Old Country Store (CBRL), Schlumberger (SLB), Brinker International (EAT), Intel (INTC), Bristol-Myers Squibb (BMY), Energy Transfer (ET), General Electric (GE) and Pfizer (PFE).

What is BRF's stock symbol?

BRF trades on the New York Stock Exchange (NYSE) under the ticker symbol "BRFS."

Who are BRF's major shareholders?

BRF's stock is owned by a number of retail and institutional investors. Top institutional investors include Macquarie Group Ltd. (1.14%), BlackRock Inc. (0.32%), BNP Paribas Arbitrage SA (0.14%), Barclays PLC (0.12%), UBS Group AG (0.08%) and Millennium Management LLC (0.07%).

Which major investors are selling BRF stock?

BRFS stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, The Manufacturers Life Insurance Company , Citadel Advisors LLC, Evolution Wealth Advisors LLC, Goldman Sachs Group Inc., Daiwa Securities Group Inc., and Alliancebernstein L.P..

Which major investors are buying BRF stock?

BRFS stock was acquired by a variety of institutional investors in the last quarter, including BNP Paribas Arbitrage SA, Millennium Management LLC, Barclays PLC, PEAK6 Investments LLC, Schonfeld Strategic Advisors LLC, American Century Companies Inc., Caption Management LLC, and Royal Bank of Canada.

How do I buy shares of BRF?

Shares of BRFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BRF's stock price today?

One share of BRFS stock can currently be purchased for approximately $3.47.

How much money does BRF make?

BRF has a market capitalization of $2.82 billion and generates $7.66 billion in revenue each year. The company earns $294.59 million in net income (profit) each year or $0.09 on an earnings per share basis.

How many employees does BRF have?

BRF employs 101,002 workers across the globe.

When was BRF founded?

BRF was founded in 1934.

What is BRF's official website?

The official website for BRF is www.brf-br.com.

Where are BRF's headquarters?

BRF is headquartered at 1400 RUA HUNGRIA 5TH FLOOR JARDIM EUROPA 01455 000, SAO PAULO SP BRAZIL D5, 01455-000.

How can I contact BRF?

BRF's mailing address is 1400 RUA HUNGRIA 5TH FLOOR JARDIM EUROPA 01455 000, SAO PAULO SP BRAZIL D5, 01455-000. The company can be reached via phone at 551123225000, via email at [email protected], or via fax at 55-11-2322-5740.